Aurinia Pharmaceuticals Inc. Active Patents
5 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2022-04-04: Application 17713140; Invention PROTOCOL FOR TREATMENT OF LUPUS NEPHRITIS; Applicant Aurinia Pharmaceuticals Inc.; Status Patented Case.
- 2019-02-08: Application 16270760; Invention Ophthalmic Compositions; Applicant Aurinia Pharmaceuticals Inc.; Status Patented Case.
- 2017-12-07: Application 15835219; Invention PROTOCOL FOR TREATMENT OF LUPUS NEPHRITIS; Applicant AURINIA PHARMACEUTICALS INC.; Status Patented Case.
- 2015-02-20: Application 14627063; Invention Ophthalmic Compositions; Applicant Aurinia Pharmaceuticals Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 | 17713140 | PROTOCOL FOR TREATMENT OF LUPUS NEPHRITIS | Aurinia Pharmaceuticals Inc. | Patented Case | 2023-04-11 | 11622991 | US20220226428A1 | Neil SOLOMONS Robert B. HUIZINGA | Canada Canada | DABKOWSKI, ERINNE R |
| 2019-02-08 | 16270760 | Ophthalmic Compositions | Aurinia Pharmaceuticals Inc. | Patented Case | 2021-04-13 | 10973871 | US20200009217A1 | Ashim K. Mitra Poonam R. Velagaleti Subramanian Natesan | United States United States India | FISHER, MELISSA L |
| 2017-12-07 | 15835219 | PROTOCOL FOR TREATMENT OF LUPUS NEPHRITIS | AURINIA PHARMACEUTICALS INC. | Patented Case | 2019-05-14 | 10286036 | US20180325995A1 | Neil SOLOMONS Robert B. HUIZINGA | Canada Canada | DABKOWSKI, ERINNE R |
| 2015-02-20 | 14627063 | Ophthalmic Compositions | Aurinia Pharmaceuticals Inc. | Patented Case | 2019-04-23 | 10265375 | US20150157687A1 | Ashim K. Mitra Poonam R. Velagaleti Subramanian Natesan | United States United States India | FISHER, MELISSA L |
| 2014-06-30 | 14320408 | CYCLOSPORINE ANALOGUE MIXTURES AND THEIR USE AS IMMUNOMODULATING AGENTS | Aurinia Pharmaceuticals Inc. | Patented Case | 2020-09-29 | RE48226 | Selvaraj A. Naicker Randall W Yatscoff Robert T Foster | Canada Canada Canada | KUGEL, TIMOTHY J |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B |